Please assess the completion status of the following clinical trial:

Trial Title: Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female 18 to 65 years old~2. Scheduled to undergo surgery to repair open tibial fracture~3. Willing and able to comply with all study procedures and be available for the duration of the study~4. Provide signed and dated informed consent or obtain consent from legally authorized representative~5. Not be pregnant, planning to become pregnant, or nursing female subjects.~Exclusion Criteria:~1. Unable to provide signed and dated informed consent or unable to obtain consent from a legally authorized representative~2. Unable or unwilling to comply with all study-related procedures~3. Known history of allergic reaction to any of the study products or its components, including any products used for standard of care (such as dressings or any coverings)~4. Subject has known history of contraindications to general anesthesia~5. Subject with any underlying condition or state that, in the investigator's opinion, will make them too critically ill to complete 30 and/or 90 day follow ups~6. Pregnant, planning to become pregnant, or nursing female subjects.~7. Any subject positive for Covid-19 virus at time of surgical screening~8. Tibial plateau, pilon, or Gustilo-Anderson type IIIc fractures and any fracture that will require referral to another surgical service will be excluded from this study~9. Any patient who will require ongoing use of NPWT after hospital discharge will be excluded from the study.~10. Subjects have evidence of prolonged QT segment, per EKG.~11. Subjects from a vulnerable population, in accordance with 45 CFR 46 Subparts B, C, and D

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Standard of Care (Type: ACTIVE_COMPARATOR): Each of the following procedures will be conducted according to general or local site Standard of Care (SoC):~* Medication administration at surgery~* Surgical irrigation and wound debridement~* Surgical fracture preparation/fixation~* Surgical closure
- Standard of Care plus Next Science (Type: EXPERIMENTAL): In addition to the SoC, the blinded product will be applied in place of saline irrigation as the wound is closed (after bone fracture preparation/fixation), depending on the randomization.

Based on this trial design, predict the completion outcome and termination type (if applicable).